Lymphoedema can occur at any time after surgery/radiotherapy, even years later, so it’s important to be aware of the symptoms and how to reduce the risk of getting. Symptoms include swelling and fluid build-up in the breast area, arm, shoulder and back causing a tight heavy uncomfortable sensation.
According to The Complete Guide to Breast Cancer by Professor Trisha Greenlagh and Dr Liz O'Riordan, after a sentinel biopsy the risk is 5-10 per cent in your lifetime, or 25 percent after axillary clearance. Treatment may involve management by exercise, massage, moisturising, support sleeves and vests.
If you suspect you have Lymphoedema contact your Breast care team or GP who can refer you o the specialist Lymphoedema team.
Lymph-What-Oedema – online information via its website and closed Facebook page www.lymph-what-oedema.com/out-and-about
Facebook Group: L-W-O Support Group
Professor Peter Mortimer. Professor of Dermatology and Lymphovascular Medicine. Dr Kristiana Gordon. Consultant of Dermatology and Lymphovascular Medicine. Professor Derek Macallan. Professor of Infectious Diseases and Medicine. Professor Sahar Mansour. Professor of Clinical Genetics.
Professor Vaughan Keeley. Professor of Palliative Medicine and Lymphoedema.
Katie Riches. Lead Research Nurse in Lymphoedema, Breast Cancer and Palliative Medicine. Dr Julian Pearce. Dermatology Registrar and Academic Clinical Fellow.
COVID-19 is an infection caused by an infectious respiratory coronavirus. Vaccinations are currently being rolled out across the U.K to help protect the population from this infectious disease. There are currently four vaccines available; none contain live forms of the virus, so you cannot get COVID-19 infection from the vaccine. The vaccine mimics parts of the virus; this triggers the immune system to produce antibodies which protect from COVID-19. The initial dose gives some protection, but protection is better after the subsequent ‘booster’ dose, given at a later date.
This consensus document aims to give advice regarding vaccination to patients with lymphoedema, based on the best available evidence and expert opinion. It is important that individual patients liaise with their General Practitioner about their own medical circumstances, as this guidance cannot cover other medical problems patients may have, which can influence suitability for vaccination. In general, patients with lymphoedema are not considered to have a weakened immune system. Some patients with rare forms of genetically inherited lymphoedema may have weakened immune systems; you will have been told if this applies to you.
The vaccination is usually given as an injection into the upper arm. Within the areas of the body affected by lymphoedema, the immune cells which fight infection may not work as well. Vaccination into these areas may therefore result in a weaker immune response and less protection from COVID- 19. Damage to the skin within an area of lymphoedema can also act as an entry site for infection, so careful skin care and protection is advisable for areas of swelling. We therefore recommend that vaccination is avoided in these areas.
We have produced the following guidance to help select the most appropriate area of the body for vaccination:
Please note that both the Pfizer and Moderna COVID-19 vaccine documents (in the footnotes) confirm that injection maybe given into the thigh. Lymph node swelling can occur after any vaccine and is a known side effect of both Moderna and Pfizer COVID-19 vaccines. It should resolve promptly after the vaccination.